CHA, Jang-Ho,DAHLKE, Frank,GARDIN, Anne,LEGANGNEUX, Eric,MALANGA III, Carl Joseph,SHAKERI-NEJAD, Kasra,WALLSTRÖM, Erik,WOLF, Christian
申请号：
AU2018343239
公开号：
AU2018343239A1
申请日:
2018.09.27
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present disclosure relates to a novel dosing regimen for the administration of siponimod or pharmaceutically acceptable co-crystals or salts thereof, in the treatment of stroke, in particular intracerebral hemorrhage (ICH).
